{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:09:00Z","timestamp":1788847740809,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00729-y","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:48:37Z","timestamp":1788788917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Testicular aggressive B-cell lymphoma with plasmablastic morphology harboring concurrent IGH::MYC and IGH::BCL2 rearrangements"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0934-3056","authenticated-orcid":false,"given":"Binnari","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-5747","authenticated-orcid":false,"given":"Hee Jeong","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"3","key":"729_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.blre.2017.12.001","volume":"32","author":"DDW Twa","year":"2018","unstructured":"Twa DDW, Mottok A, Savage KJ, Steidl C (2018) The pathobiology of primary testicular diffuse large B-cell lymphoma: implications for novel therapies. Blood Rev 32(3):249\u2013255","journal-title":"Blood Rev"},{"issue":"4","key":"729_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/blood-2013-10-530659","volume":"123","author":"CY Cheah","year":"2014","unstructured":"Cheah CY, Wirth A, Seymour JF (2014) Primary testicular lymphoma. Blood 123(4):486\u2013493","journal-title":"Blood"},{"issue":"3","key":"729_CR3","first-page":"3113","volume":"17","author":"H Xu","year":"2019","unstructured":"Xu H, Yao F (2019) Primary testicular lymphoma: a SEER analysis of 1,169 cases. Oncol Lett 17(3):3113\u20133124","journal-title":"Oncol Lett"},{"issue":"8","key":"729_CR4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3324\/haematol.2009.016113","volume":"95","author":"S Montes-Moreno","year":"2010","unstructured":"Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, Maestre L, Sanchez-Verde L, Roncador G et al (2010) Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica 95(8):1342\u20131349","journal-title":"Haematologica"},{"issue":"2","key":"729_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/10428194.2011.608447","volume":"53","author":"S Montes-Moreno","year":"2012","unstructured":"Montes-Moreno S, Montalb\u00e1n C, Piris MA (2012) Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge. Leuk Lymphoma 53(2):185\u2013194","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"729_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1309\/AJCPWY1SGJ9IEAOR","volume":"134","author":"I Ouansafi","year":"2010","unstructured":"Ouansafi I, He B, Fraser C, Nie K, Mathew S, Bhanji R et al (2010) Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. Am J Clin Pathol 134(6):972\u2013981","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"729_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3960\/jslrt.18003","volume":"58","author":"M Ise","year":"2018","unstructured":"Ise M, Kageyama H, Ikebe D, Araki A, Kumagai K, Itami M (2018) Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement. J Clin Exp Hematop 58(3):128\u2013135","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"729_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","volume":"37","author":"D Martinez","year":"2013","unstructured":"Martinez D, Valera A, Perez NS, Sua Villegas LF, Gonzalez-Farre B, Sole C et al (2013) Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases. Am J Surg Pathol 37(2):272\u2013281","journal-title":"Am J Surg Pathol"},{"key":"729_CR9","doi-asserted-by":"publisher","unstructured":"Lyle A, Patel JL, Venkataraman G, Menon MP (2026) A \u201cdouble-hit\u201d lymphoma with plasmablastic features and aberrant keratin expression likely transforming from follicular lymphoma. Int J Surg Pathol. https:\/\/doi.org\/10.1177\/10668969261455058","DOI":"10.1177\/10668969261455058"},{"issue":"3","key":"729_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/jha2.513","volume":"3","author":"M Barouqa","year":"2022","unstructured":"Barouqa M, Greipp P, King R, McPhail ED (2022) Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement. EJHaem 3(3):1080\u20131081","journal-title":"EJHaem"},{"key":"729_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1784860","volume":"16","author":"J Xu","year":"2026","unstructured":"Xu J, Liu Y, Feng X, Zhao D, Liu K, Cui S et al (2026) Case report: clonal evolution of diffuse large B-cell lymphoma to plasmablastic lymphoma: diagnostic challenges in a case of gastric lesion with EBV-negative PBL. Front Oncol 16:1784860","journal-title":"Front Oncol"},{"issue":"1","key":"729_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s44313-025-00070-w","volume":"60","author":"BJ Chen","year":"2025","unstructured":"Chen BJ, Kuo YT, Chang ST, Win KT, Chen SW, Hsiao SY et al (2025) Frequent association of malignant effusions in plasmablastic lymphoma: a single-institutional experience of nine cases in Taiwan. Blood Res 60(1):22","journal-title":"Blood Res"},{"issue":"4","key":"729_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pathol.2020.03.004","volume":"52","author":"MH Huang","year":"2020","unstructured":"Huang MH, Chen BJ, Chang ST, Hsieh YC, Chuang SS (2020) Double-hit plasmablastic lymphoma with malignant pleural effusion and leukaemic presentation. Pathology 52(4):488\u2013491","journal-title":"Pathology"},{"issue":"Suppl 1(Suppl 1","key":"729_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/ijlh.13863","volume":"44","author":"J Bailly","year":"2022","unstructured":"Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ (2022) Plasmablastic lymphoma: an update. Int J Lab Hematol 44(Suppl 1(Suppl 1)):54\u201363","journal-title":"Int J Lab Hematol"},{"key":"729_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/315289","volume":"2015","author":"G Elyamany","year":"2015","unstructured":"Elyamany G, Al Mussaed E, Alzahrani AM (2015) Plasmablastic lymphoma: a review of current knowledge and future directions. Adv Hematol. 2015:315289","journal-title":"Adv Hematol."},{"issue":"11","key":"729_CR16","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","volume":"34","author":"A Valera","year":"2010","unstructured":"Valera A, Balagu\u00e9 O, Colomo L, Mart\u00ednez A, Delabie J, Taddesse-Heath L et al (2010) IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol 34(11):1686\u20131694","journal-title":"Am J Surg Pathol"},{"key":"729_CR17","doi-asserted-by":"crossref","unstructured":"Bibas M, Antinori A, Mazzotta V, Marafioti T, Castillo JJ (2025) The genetic and epigenetic alterations of plasmablastic lymphoma: a narrative review. Cancers (Basel) 17(12):1914","DOI":"10.3390\/cancers17121914"},{"issue":"1","key":"729_CR18","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1038\/s41467-021-25405-w","volume":"12","author":"F Frontzek","year":"2021","unstructured":"Frontzek F, Staiger AM, Zapukhlyak M, Xu W, Bonzheim I, Borgmann V et al (2021) Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nat Commun 12(1):5183","journal-title":"Nat Commun"},{"issue":"1","key":"729_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/10428194.2020.1821012","volume":"62","author":"EA Kaya","year":"2021","unstructured":"Kaya EA, Baughn LB, Pham T, Ketterling RP, Kumar SK, Jevremovic D (2021) Lymphoma-like double-hit genetic abnormalities (MYC\/IGH and IGH\/BCL2) in a case of non-secretory multiple myeloma. Leuk Lymphoma 62(1):243\u2013246","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"729_CR20","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.3324\/haematol.2014.111385","volume":"100","author":"A Kalff","year":"2015","unstructured":"Kalff A, Khong T, Wall M, Gorniak M, Mithraprabhu S, Campbell LJ et al (2015) A rare case of IGH\/MYC and IGH\/BCL2 double hit primary plasma cell leukemia. Haematologica 100(2):e60","journal-title":"Haematologica"},{"issue":"1","key":"729_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-024-01512-2","volume":"19","author":"S Lim","year":"2024","unstructured":"Lim S, Koh J, Bae JM, Yun H, Lee C, Paik JH et al (2024) Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution. Diagn Pathol 19(1):86","journal-title":"Diagn Pathol"},{"issue":"7","key":"729_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2009-10-247122","volume":"116","author":"F Jardin","year":"2010","unstructured":"Jardin F, Jais JP, Molina TJ, Parmentier F, Picquenot JM, Ruminy P et al (2010) Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study. Blood 116(7):1092\u2013104","journal-title":"Blood"},{"issue":"4","key":"729_CR23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","volume":"106","author":"J Garcia-Reyero","year":"2021","unstructured":"Garcia-Reyero J, Martinez Magunacelaya N, Gonzalez de Villambrosia S, Loghavi S, Gomez Mediavilla A, Tonda R et al (2021) Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. Haematologica. 106(4):1120\u20138","journal-title":"Haematologica."},{"issue":"7","key":"729_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","volume":"127","author":"B Chapuy","year":"2016","unstructured":"Chapuy B, Roemer MG, Stewart C, Tan Y, Abo RP, Zhang L et al (2016) Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood 127(7):869\u2013881","journal-title":"Blood"},{"issue":"13","key":"729_CR25","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1182\/blood.2021011366","volume":"138","author":"M Minderman","year":"2021","unstructured":"Minderman M, Amir A, Kraan W, Schilder-Tol EJM, Oud M, Scheepstra CG et al (2021) Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1\/PD-L1\/PD-L2 alterations. Blood 138(13):1194\u20137","journal-title":"Blood"},{"issue":"10","key":"729_CR26","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3324\/haematol.2011.060186","volume":"97","author":"M Schmelz","year":"2012","unstructured":"Schmelz M, Montes-Moreno S, Piris M, Wilkinson ST, Rimsza LM (2012) Lack and\/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma. Haematologica 97(10):1614\u20136","journal-title":"Haematologica"},{"issue":"7","key":"729_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/cyto.a.20557","volume":"73","author":"D Alp\u00e1r","year":"2008","unstructured":"Alp\u00e1r D, Hermesz J, P\u00f3t\u00f3 L, L\u00e1szl\u00f3 R, Kereskai L, J\u00e1ks\u00f3 P et al (2008) Automated FISH analysis using dual-fusion and break-apart probes on paraffin-embedded tissue sections. Cytometry A 73(7):651\u2013657","journal-title":"Cytometry A"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00729-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:02:41Z","timestamp":1788847361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00729-y","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"6 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ulsan University Hospital Institutional Review Board (R-BAY File No. 2026-06-042).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived by the Institutional Review Board.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, consent for publication is not required.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"52"}}